19 reviews
2011
Gott M, Ward S, Gardiner C,Cobb M, Ingleton C. A narrative literature review of the evidence regarding the econonmic impact of avoidable hospitalizations amongst palliative care patients in the UK.Prog Palliat Care. 2011;19(6):291-298.
2010
Allen JM. Economic/societal burden of metastatic breast cancer: a US perspective. Am J Manag Care. 2010 Sep;16(9):697-704.
Genevro JL, Miller TL. The emotional and economic costs of bereavement in health care settings. Psychologica Belgica. 2010;50(1-2):69-88.
Loveman E, Jones J, Hartwell D, Bird A, Harris P, Welch K, Clegg A. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Health Technol Assess. 2010 Mar;14(19):1-204.
Simoens S, Kutten B, Keirse E, Berghe PV, Beguin C, Desmedt M, Deveugele M, Léonard C, Paulus D, Menten J. The costs of treating terminal patients. J Pain Symptom Manage. 2010 Sep;40(3):436-48. Epub 2010 Jun 25.
2009
Tappenden P, Chilcott J, Brennan A, Pilgrim H. Systematic review of economic evidence for the detection, diagnosis, treatment, and follow-up of colorectal cancer in the United Kingdom. Int J Technol Assess Health Care. 2009 Oct;25(4):470-8.
2008
Cashin RP, Lui P, Machado M, Hemels ME, Corey-Lisle PK, Einarson TR. Advanced cutaneous malignant melanoma: a systematic review of economic and quality-of-life studies. Value Health. 2008 Mar-Apr;11(2):259-71.
Gelfman LP, Morrison RS. Research funding for palliative medicine. J Palliat Med. 2008 Jan-Feb;11(1):36-43.
Hatziandreu E, Archontakis F, Daly A. The potential cost savings of greater use of home- and hospice- based end of life care in England. RAND Technical Report; TR-642-NAO. 2008 Jan;116pp.
Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008 Jul-Aug;11(4):733-41. Epub 2008 Jan 8.
Murphy G, Perras C, Desjardins B, Chen S, Moulton K, Jonker D, Perlman K, Pasieka J, Ezzat S, Cripps C, Mensinkai M, Skidmore B. Octreotide for endocrine, oncologic, and gastrointestinal disorders: systematic review and budget impact analysis. [Technology overview number 45]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2008 Jul;10pp.
Wilson K, Amir Z. Cancer and disability benefits: a synthesis of qualitative findings on advice and support. Psychooncology. 2008 May;17(5):421-9.
Wright M, Wood J, Lynch T, Clark D. Mapping levels of palliative care development: a global view. J Pain Symptom Manage. 2008 May;35(5):469-85. Epub 2008 Feb 4.
2007
Hugodot A, Normand C. Cost-effectiveness of palliative care in hospital: a review of the literature (part 3). Centre for Health Policy and Management, University of Dublin. 2007 Jun 11:23pp.
Mason A, Weatherly H, Spilsbury K, Golder S, Arksey H, Adamson J, Drummond M. The effectiveness and cost-effectiveness of respite for caregivers of frail older people. J Am Geriatr Soc. 2007 Feb;55(2):290-9.
2006
Smith P, Payne S, Ramcharan P, Chapman A, Patterson M. Carers of the terminally ill and employment issues: a comprehensive literature review. Palliative and End-of-Life Research Group, University of Sheffield. 2006 Jan;31pp.
2003
Douglas HR, Halliday D, Normand C, Corner J, Bath P, Beech N, Clark D, Hughes P, Marples R, Seymour J, Skilbeck J, Webb T. Economic evaluation of specialist cancer and palliative nursing: Macmillan evaluation study findings. Int J Palliat Nurs. 2003 Oct;9(10):429-38.
2001
Thomsen AB, Sorensen J, Sjogren P, Eriksen J. Economic evaluation of multidisciplinary pain management in chronic pain patients: a qualitative systematic review. J Pain Symptom Manage. 2001 Aug;22(2):688-98.
1997
Hughes SL, Ulasevich A, Weaver FM, Henderson W, Manheim L, Kubal JD, Bonarigo F. Impact of home care on hospital days: a meta analysis. Health Serv Res. 1997 Oct;32(4):415-32.